Sativex® for MS spasticity launched in Denmark

A cannabis derived drug which has been approved in some countries to treat muscle spasticity.

Sativex® for MS spasticity launched in Denmark

Postby MSUK » Mon Jul 18, 2011 12:25 am


GW Pharmaceuticals plc today announces the launch in Denmark of Sativex® oromucosal spray as a treatment for the relief of spasticity in Multiple Sclerosis (MS).

Regulatory approval for Sativex® was granted in June 2011 by the health authorities in Denmark.

Sativex® was developed by UK-based GW Pharmaceuticals plc in specific response to the MS population's unmet need for a prescription cannabis-based medicine. Manufactured under Home Office licence at an undisclosed location in the UK it is marketed in Europe (except the UK) by Almirall.... Read More - ... ageid/1814
User avatar
Family Elder
Posts: 2868
Joined: Wed Oct 14, 2009 2:00 pm


Return to Sativex


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service